Brexit: Industry should keep Timelines for Batch Testing Facilities
Recommendation
11/12 February 2025
Heidelberg, Germany
Medicinal Products/Drugs meet Medical Devices
In a reminder sent out to stakeholders the European Medicines Agency (EMA) points out that - independent from the extension of the date for the UK's withdrawal from the EU ('Brexit') to 31 October 2019 - Marketing Authorisation Holders (MAHs) should use the remaining time to complete all necessary preparations. This means that by 1 January 2020 all batch testing sites must be fully transferred to the remaining EU27 Member States and/or EEA countries. Also the necessary regulatory submissions must be completed by then. This includes MAHs who have the permission to perform quality control testing in the UK even after Brexit. "The transfer should be completed quickly and in principle by the end of 2019 at the latest", EMA writes on their website with Brexit related guidance documents. Companies should check this page regularly.
Related GMP News
16.01.20252nd Version of the Union list of Critical Medicines published
16.01.2025Securing Europe's Drug Supply: How EDSForm is Addressing Medicine Shortages
15.01.2025FDA proposes Standardized Testing for Asbestos in Talc-Containing Cosmetic Products
18.12.2024What are the GMP Requirements for Consultants?
18.12.2024ICH published updated Q8/Q9/Q10 Questions & Answers Document
11.12.2024European Shortages Monitoring Platform (ESMP) has gone live